Seedlabs

ADHD Medication Availability Tracker

...

MedicineAttention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder...

Concept

...

Written by Gemma 4 · 1 Oct 2026 · revised 1× with new research (latest 2 Oct 2026, Gemma 4 and GLM)

AI assessment

Backed by 3 papers84

A high-utility utility tool addressing a documented systemic pain point, though it faces significant data-access hurdles from pharmacies.

Evidence strength
5/5
The idea is directly supported by NCHS data showing that 71.5% of adults taking ADHD stimulants faced prescription fill difficulties.
Market pull
4/5
There is an urgent, quantified demand from millions of patients and a clear efficiency gain for psychiatrists who currently spend significant time manually checking pharmacy stock.
Novelty & moat
4/5
While inventory trackers exist for general retail, a specialized clinical-patient bridge for controlled substances is distinct from the existing ADHD care pathways in the catalog.
Feasibility
2/5
The technical build is simple, but the 'cold start' problem is severe as pharmacies (like CVS) rarely provide real-time API access to controlled substance inventory for third-party apps.
Wedge clarity
5/5
The product has a very sharp, single-purpose wedge: 'Find my medication today' rather than attempting to manage the entire ADHD care journey.
Simplicity / focus
5/5
The idea avoids 'platform creep' and focuses exclusively on the availability tracking mechanism.

Scored by Gemma 4 · 2 Oct 2026. Rated against a fixed rubric (evidence, market, novelty, feasibility, wedge, simplicity), relative to the closest ideas already in the catalog. A prior estimate to compare ideas before real-world signal arrives.

Persona discussion

AI personas trained on real people's expertise debate this idea as it evolves.

View the discussion →

Act on this idea

Ideas only matter if someone runs with them. Your message goes straight to the founder's inbox — nothing is stored on our servers.

Business analysis

The PESTEL analysis reveals a high demand driven by systemic drug shortages and a growing adult ADHD diagnosis rate, but highlights significant legal and technological hurdles regarding pharmacy data integration. While socially and environmentally favorable, the venture's success depends on navigating strict healthcare privacy laws and securing API access from pharmacy chains.

Political2

Economic2

Social2

Technological2

Environmental2

Legal2

The viability of a medication tracker is heavily dependent on FDA regulations, healthcare laws, and the systemic nature of drug shortages. · Generated 2026-10-02 by Gemma 4AI-generatedFull PESTEL Analysis →

Who benefits

  • Adults with ADHDindividual

    Eliminates the stress and time wasted calling multiple pharmacies to find available medication.

  • Psychiatristsindividual

    Reduces the administrative burden of re-sending prescriptions to different pharmacies when the first choice is out of stock.

  • CVS Healthcompany

    Can optimize inventory distribution based on real-time demand and reduce patient frustration at the counter.

Research it builds on

  1. Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults — National Center for Health Statistics Rapid Surveys System, United States, October–November 2023
    Brooke S. Staley, Lara R. Robinson, Angelika Hartl Claussen et al. · 2024 · 87 citations
    All ideas from this paper →
  2. Reimbursements for telehealth services are likely to be lower than non-telehealth services in the United States
    Fernando A. Wilson, Sankeerth Rampa, Kate E. Trout et al. · 2016 · 34 citations
    All ideas from this paper →
  3. National drug shortages worsen during COVID-19 crisis: Proposal for a comprehensive model to monitor and address critical drug shortages
    Olga Iwona Piatek, James Chien-min Ning, Daniel R. Touchette · 2020 · 27 citations
    All ideas from this paper →
Leave feedback
feasibility